MicroRNAs in peritoneal dialysis effluent are promising biomarkers for peritoneal fibrosis in peritoneal dialysis patients

Medical Hypotheses

Volumn 78, Issue 1, 2012, Pages 155-156

  Ge, Yan ^a   Xiao, Li ^a   Chen, Xiaojun ^a   Peng, Youming ^a   Sun, Lin ^a   Liu, Fuyou ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 183; MICRORNA 24; MICRORNA 26B; MICRORNA 452; MICRORNA 96; PERITONEAL DIALYSIS FLUID; UNCLASSIFIED DRUG;

AMNION FLUID; ARTICLE; ASCITES; BODY FLUID; BREAST MILK; CEREBROSPINAL FLUID; COLOSTRUM; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EARLY INTERVENTION; EFFLUENT; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HEMODIALYSIS PATIENT; HUMAN; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEAL FLUID; PH; PLEURA FLUID; PROTEIN BLOOD LEVEL; RNA ANALYSIS; SALIVA ANALYSIS; SEMINAL PLASMA; TRACHEOBRONCHIAL TOILET; URINALYSIS;

BIOLOGICAL MARKERS; DIALYSIS SOLUTIONS; HUMANS; MICRORNAS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS;

EID: 83155175095     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.10.015     Document Type: Article

References (21)

1. Miyazaki M., Yuzawa Y. The role of peritoneal fibrosis in encapsulating peritoneal sclerosis. Perit Dial Int 2005, 25(Suppl. 4):S48-56.
2. Williams J.D., Craig K.J., Topley N., et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002, 13:470-479.
3. Schetter A.J., Leung S.Y., Sohn J.J., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama 2008, 299:425-436.
4. Chung G.E., Yoon J.H., Myung S.J., et al. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol Rep 2010, 23:113-119.
5. Xiong F., Wu C., Chang J., et al. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 2011, 71:5175-5181.
6. Zhang Y., Jia Y., Zheng R., et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010, 56:1830-1838.
7. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009, 55:1944-1949.
8. Wang G., Tam L., Li E.K., et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2010.
9. Alevizos I., Illei G.G. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev 2011, 6:391-398.
10. Roderburg C., Urban G.W., Bettermann K., et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology (Baltimore, Md) 2011, 53:209-218.
11. Chen X., Ba Y., Ma L., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
12. van Rooij E., Sutherland L.B., Thatcher J.E., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008, 105:13027-13032.
13. Maurer B., Stanczyk J., Jungel A., et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheumat 2010, 62:1733-1743.
14. Cushing L., Kuang P.P., Qian J., et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Resp Cell Mol Biol 2011, 45:287-294.
15. Xie Y., Todd N.W., Liu Z., et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 2010, 67:170-176.
16. Weber J.A., Baxter D.H., Zhang S., et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010, 56:1733-1741.
17. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
18. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genom 2007, 8:166.
19. Xie L., Wang T., Yu S., et al. Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions. Clin Biochem 2011, 44:216-220.
20. Xie L., Chen X., Wang L., et al. Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer 2010, 10:591.
21. Yamada Y., Enokida H., Kojima S., et al. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 2010, 102:522-529.